Gene Expression Profiles of Uterine Normal Myometrium and Leiomyoma and Their Estrogen Responsiveness In Vitro
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Background : Uterine leiomyomas are common benign smooth muscle tumors among the reproductive aged-women. The research has been aimed to identify the differentially expressed genes between normal myometrium and leiomyoma and to investigate the effects of E2 on their expression. Methods : Gene microarray analysis was performed to identify the differentially expressed genes between normal myomerium and leiomyoma. The data was confirmed at protein level by tissue microarray. Results : Gene microarray analysis revealed 792 upregulated genes in leiomyoma. Four genes (tropomyosin 4 [TPM4], collagen, type IV, alpha 2 [COL4α2], insulin-like growth factor binding protein 5 [IGFBP5], tripartite motif-containing 28 [TRIM28]) showed the most dramatic upregulation in all leiomyoma samples. Tissue microarray analyses of 262 sample pairs showed significantly elevated expression of TPM4, IGFBP5, estrogen receptor-α, and progesterone receptor (PR) protein in leiomyoma from the patients in theirforties, COL4α2 in the forties and fifties age-groups, and TRIM28 in the thirties age-group. PR, insulin-like growth factor 1 (IGF-1), IGF-1 receptor (IGF-1R) and IGFBP5 were induced by E2 in in vitro culture of tissue explants from which cells migrated throughout the plate. Among these, PR, IGF-1, IGFBP5 genes showed higher expression in tissue compared to cells-derived from tissue in leiomyoma and IGF-1R in leiomyoma cell. Conclusions : This observation implies the importance of the whole tissue context including the cells-derived from tissue in the research for the understanding of molecular mechanism of leiomyoma. Here, we report higher expression of TRIM28 in leiomyoma for the first time and identify E2-responsive genes that may have important roles in leiomyoma development.
Abstract
Background : Uterine leiomyomas are common benign smooth muscle tumors among the reproductive aged-women. The research has been aimed to identify the differentially expressed genes between normal myometrium and leiomyoma and to investigate the effects of E2 on their expression. Methods : Gene microarray analysis was performed to identify the differentially expressed genes between normal myomerium and leiomyoma. The data was confirmed at protein level by tissue microarray. Results : Gene microarray analysis revealed 792 upregulated genes in leiomyoma. Four genes (tropomyosin 4 [TPM4], collagen, type IV, alpha 2 [COL4α2], insulin-like growth factor binding protein 5 [IGFBP5], tripartite motif-containing 28 [TRIM28]) showed the most dramatic upregulation in all leiomyoma samples. Tissue microarray analyses of 262 sample pairs showed significantly elevated expression of TPM4, IGFBP5, estrogen receptor-α, and progesterone receptor (PR) protein in leiomyoma from the patients in theirforties, COL4α2 in the forties and fifties age-groups, and TRIM28 in the thirties age-group. PR, insulin-like growth factor 1 (IGF-1), IGF-1 receptor (IGF-1R) and IGFBP5 were induced by E2 in in vitro culture of tissue explants from which cells migrated throughout the plate. Among these, PR, IGF-1, IGFBP5 genes showed higher expression in tissue compared to cells-derived from tissue in leiomyoma and IGF-1R in leiomyoma cell. Conclusions : This observation implies the importance of the whole tissue context including the cells-derived from tissue in the research for the understanding of molecular mechanism of leiomyoma. Here, we report higher expression of TRIM28 in leiomyoma for the first time and identify E2-responsive genes that may have important roles in leiomyoma development.
참고문헌 (28)
- Walker CL, "Uterine fibroids:the elephant in the room", Science, 308, pp.1589~1592 (2005)
- Lethaby A, "Fibroids(uterine myomatosis,leiomyomas)", Clin Evid, (7), pp.1666~1678 (2002)
- Jemal A, "Cancer statistics,2008", CA Cancer J Clin, 58, pp.71~96 (2008)
- Zaitseva M, "In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells", Mol Hum Reprod, 12, pp.187~207 (2006)
- Shalon D, "A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization", Genome Res, 6, pp.639~645 (1996)
- Kallioniemi OP, "Tissue microarray technology for high-throughput molecular profiling of cancer", Hum Mol Genet, 10, pp.657~662 (2001)
- Hansen RK, "Tissue architecture and breast cancer:the role of extracellular matrix and steroid hormones", Endocr Relat Cancer, 7, pp.95~113 (2000)
- Young RC, "Three-dimensional culture of human uterine smooth muscle myocytes on a resorbable scaffolding", Tissue Eng, 9, pp.451~459 (2003)
- Parker WH, "Etiology,symptomatology,and diagnosis of uterine myomas", Fertil Steril, 87, pp.725~736 (2007)
- Friedman AJ, "Clinical experience in the treatment of fibroids with leuprolide and other GnRH agonists", Obstet Gynecol Surv, 44, pp.311~313 (1989)
- Cook JD, "Treatment strategies for uterine leiomyoma:the role of hormonal modulation", Semin Reprod Med, 22, pp.105~111 (2004)
- Andersen J, "Abnormal gene expression in uterine leiomy omas", J Soc Gynecol Investig, 2, pp.663~672 (1995)
- Choi I, "Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region", Mol Cell Endocrinol, 164, pp.225~237 (2000)
- Kononen J, "Tissue microarrays for high-throughput molecular profiling of tumor specimens", Nat Med, 4, pp.844~847 (1998)
- Cammas F, "Cell differentiation induces TIF1beta association with centromeric heterochromatin via an HP1 interaction", J Cell Sci, 115, pp.3439~3448 (2002)
- Lurie S, "Age-related prevalence of sonographicaly confirmed uterine myomas", J Obstet Gynaecol, 25, pp.42~44 (2005)
- Vollenhoven BJ, "Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women", Clin Endocrinol(Oxf), 40, pp.537~544 (1994)
- Breuiller-Fouché M, "EndothelinA receptors in human uterine leiomyomas", Obstet Gynecol, 90, pp.727~730 (1997)
- Lessl M, "Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium", J Clin Endocrinol Metab, 82, pp.2596~2600 (1997)
- Weston G, "Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium", Mol Hum Reprod, 9, pp.541~549 (2003)
- Martin Chaves EB, "Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma", Gynecol Obstet Invest, 57, pp.210~213 (2004)
- Giudice LC, "Insulin-like growth factor(IGF),IGF binding protein(IGFBP),and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata", Hum Reprod, 8, pp.1796~1806 (1993)
- Yamawaki-Kataoka Y, "Isolation and characterization of cDNA clones encoding a low molecular weight nonmuscle tropomyosin isoform", J Biol Chem, 262, pp.10791~10800 (1987)
- White DE, "KAP1,a novel substrate for PIKK family members,colocalizes with numerous damage response factors at DNA lesions", Cancer Res, 66, pp.11594~11599 (2006)
- Malik M, "Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays", Fertil Steril, 87, pp.1166~11172 (2007)
- Nowak RA, "Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors", J Clin Endocrinol Metab, 76, pp.1308~1313 (1993)
- Zhang JC, "The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin", Proc Natl Acad Sci U S A, 99, pp.12224~12229 (2002)
- Roth JM, "Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions,induces cellular senescence,and inhibits tumor growth in vivo", Am J Pathol, 166, pp.901~911 (2005)